Navigation Links
Trius Announces Positive Results From Phase 2 Clinical Trial of Torezolid in Patients With Complicated Skin and Skin Structure Infections
Date:6/8/2009

nst drug-resistant, gram-positive bacterial pathogens including those resistant to linezolid, the only currently marketed antibacterial drug of the oxazolidinone class. Trius' pipeline includes two preclinical programs with lead candidates for serious infections caused by gram-negative bacterial pathogens. For more information, visit www.triusrx.com.


'/>"/>
SOURCE Trius Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases
2. Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections
3. Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA
4. Trius Doses First Patient in Antibacterial Phase 2 Trial
5. PacificGMP Completes GMP Product Fill for Trius Therapeutics
6. Trius Initiates U.S. Phase I Trial for its Oxazolidinone Antibacterial Drug, TR-701
7. Merz Pharmaceuticals Announces Results of Clinical Trials with NT-201(Botulinum neurotoxin type A free from complexing proteins) at Annual Movement Disorders Society Meeting
8. Lilly Announces Positive Phase II Data on Investigational Medicine for Patients with Type 2 Diabetes
9. Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk
10. Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
11. Cardiogenesis Announces Presentation of its PHOENIX(R) Combination TMR Plus Stem Cell Delivery System at the International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...rlandsandJOHANNESBURG,November25/PRNewswire/--,iTh...ryannouncedtoday,thattheyhavesignedacollaborativea..., Pyxis,sworldclasscomputationalchemistryandlea...icedivisiontoprovidemedicinaland,syntheticchemistr...ionalclientnetwork.iThembaPharmaceuticalsandPyxisD...
(Date:11/24/2009)....24/PRNewswire/-- ,, WHAT:RomHoubens,aBelgianma...ccident,wasactuallyfullyconsciousandawakeduringtha...TheDynaVoxEyeMaxwasfeaturedinthesegmenttoillustrat...anunlockcommunication. ,, WHEN:GoodMorningAmeri...ynavoxtech.com ,, WHO:RomHoubenswasanengine...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--AnadysPharmaceuticals,Inc...he21stAnnualPiperJaffrayHealthcareConferenceonTues...nferenceisbeingheldatTheNewYorkPalaceHotel.SteveWo...dys,willprovideanoverviewofAnadysanditsclinicaldev...tepresentationwillbesimultaneouslywebcastandcanbea...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2CombinatoRx and Neuromed Sign Merger Agreement 50637 1CombinatoRx and Neuromed Sign Merger Agreement 50637 2CombinatoRx and Neuromed Sign Merger Agreement 50637 3CombinatoRx and Neuromed Sign Merger Agreement 50637 4CombinatoRx and Neuromed Sign Merger Agreement 50637 5CombinatoRx and Neuromed Sign Merger Agreement 50637 6CombinatoRx and Neuromed Sign Merger Agreement 50637 7CombinatoRx and Neuromed Sign Merger Agreement 50637 8CombinatoRx and Neuromed Sign Merger Agreement 50637 9Triple S Management Corporation Schedules Second Quarter Earnings Release and Webcast 50633 1Triple S Management Corporation Schedules Second Quarter Earnings Release and Webcast 50633 2Study Casts Doubt on Low IQs Role in Early Death 50630 1Study Casts Doubt on Low IQs Role in Early Death 50630 2
...technologies, inc., a privately held company focus...peutics (MAbs) for cancer, today announced it,is c...lerated dose cohort,expansion segment of its Phase...ointestinal tract that express the RAAG12 antigen.... widely found on the,surface of tumor cells of man...
...LC,announced today that their drug KX2-391 (KX01) ...tled "A combined rising single-dose (RSD) and,risi...afety, tolerability,and pharmacokinetics of KX2-39...refractory to conventional therapies". The drug be... treatments called protein kinase inhibitors., Do...
Other Medicine Technology:Raven Announces Continued Enrollment of Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas 2Raven Announces Continued Enrollment of Phase 1/2a Clinical Trial of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas 3First Patient Dosed with KX2-391 in Phase 1 Clinical Trial 2
(Date:11/25/2009)...E,Calif.,Nov.25/PRNewswire-FirstCall/-- OnyxPharm...ecompanywillhosttwoinvestoreventsinDecember: ,,.../10:00a.m.ET ,, Principalinvestigatorswilldis...sedand/orrefractorymultiplemyeloma,asfeaturedatthe...ndExpositioninNewOrleans,LA.Theteleconferencewillb...
(Date:11/25/2009)...ov.25/PRNewswire/-SentinelleMedicalInc.,aleadingma...softwarelaunchesasuiteofnewleadingedgeclinicalappl...rmatthisyear,sRadiologicalSocietyofNorthAmerica(RS...800,HallA).Theapplicationsleveragetheuniquehighqua...gingcoilsandsupportmultipleimagingmodalitiesformul...
(Date:11/25/2009)...ING,Md.,Nov.25/PRNewswire-USNewswire/--Anarticleby...EvaluationandResearch,titled"ADifficultBalance-Pai...26,2009issueofTheNewEnglandJournalofMedicine. ,...824/FDALOGO ) ,, Inthearticle,Woodcockdiscusses...ationforthosewhoneeditandmanagingtherisksposedbyva...
(Date:11/25/2009)...SCO,Nov.25/PRNewswire/--TheBayAreaAirQualityManage...are the Air Alert forThursday,November2...nyothersolidfuel,bothindoorsandoutdoors. ,, "Co...tomorrow,"saidJackBroadbent,executiveofficeroftheA...ehealthoftheirneighborsandfellowcommunitymembersth...
(Date:11/25/2009)...vors of testicular cancer who were treated with ci...fects, including neurological side effects and Ray... with chemotherapy, according to a new study publi...ional Cancer Institute . , Marianne Brydy, M.D.,...ty Hospital, in Bergen, Norway, and colleagues con...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2
...f medicine have found that patients who had stroke...wed arteries in head are in the risk of developing...onducted by Professor Scott Kasner and researchers...l for patients who had stroke and this follow up i...
...se for the elderly. In the direction of its treatm...hange: EVT, TecDAX 30, "Evotec") has successfully ...f the Phase I clinical study with EVT 101, a subty...that EVT 101 was well absorbed, extremely well tol...
...Fox Run on 5 February 2006 in memory of a young Ca...e of cancer research. More than 3,000 // people ar...ildren. They can participate using cycles, or even...chools and individuals. Canadian High Commissioner...
... in Scotland, called, Generation Scotland would lo... cancer, heart disease and mental // illness. ...Universities of Aberdeen, Dundee, Edinburgh and Gl...d in full and close collaboration with the NHS in ...
... expected in poultry during the course of 2006, ac...is is not expected to take place // among human be...tions in Iraq and Turkey. Governments have howeve...ase is concerned. Large-scale infections in Iraq h...
...ter (IEEC) of the Binghamton University has receiv...York State Office of Science, Technology and Acade...e Microelectronics Research in the roll-to-roll fo... innovation of cutting edge technology. The IEEC a...
Other Medicine News:Health News:Public Health awareness to help scientists in Scotland! 2Health News:Public Health awareness to help scientists in Scotland! 3Health News:$ 1.7 Million NYSTAR Award for Binghamton University to Flex Electronics Research Muscle. 2
Surgical Loupes
...lity full-coverage body imaging. New Freewave data...tecture. New powerful Quasar Dual gradients design...200. New RF-Smart developed for SAR management to ...ronment. Sense is an essential element for imaging...
...er negative lens delivering magnification of 2.0x,... ease of use. Movement whilst maintaining focal cl...field. The ultra lightweight aluminum bar and indi...y for the mounted loupes and optimal focal alignme...
...presents a breakthrough for patients experiencing ...he system gathers bone during decompression, bone ...g of bone into the implant's chamber produces a lo...m the iliac crest. The BAK/C implant is constructe...
Medicine Products: